Standard
Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients. / Kielgast, Urd; Asmar, Meena; Madsbad, Sten; Holst, Jens Juul.
In:
Journal of Clinical Endocrinology and Metabolism, Vol. 95, No. 5, 2010, p. 2492-6.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Kielgast, U, Asmar, M
, Madsbad, S & Holst, JJ 2010, '
Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients',
Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 5, pp. 2492-6.
https://doi.org/10.1210/jc.2009-2440
APA
Kielgast, U., Asmar, M.
, Madsbad, S., & Holst, J. J. (2010).
Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients.
Journal of Clinical Endocrinology and Metabolism,
95(5), 2492-6.
https://doi.org/10.1210/jc.2009-2440
Vancouver
Kielgast U, Asmar M
, Madsbad S, Holst JJ.
Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients.
Journal of Clinical Endocrinology and Metabolism. 2010;95(5):2492-6.
https://doi.org/10.1210/jc.2009-2440
Author
Kielgast, Urd ; Asmar, Meena ; Madsbad, Sten ; Holst, Jens Juul. / Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients. In: Journal of Clinical Endocrinology and Metabolism. 2010 ; Vol. 95, No. 5. pp. 2492-6.
Bibtex
@article{1b1a4a189cd444de86747f34c4d22a62,
title = "Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients",
abstract = "The mechanism by which glucagon-like peptide-1 (GLP-1) suppresses glucagon secretion is uncertain, and it is not determined whether endogenous insulin is a necessary factor for this effect.",
keywords = "Arginine, Blood Glucose, C-Peptide, Diabetes Mellitus, Type 1, Glucagon, Glucagon-Like Peptide 1, Glucagon-Secreting Cells, Humans, Hyperglycemia, Insulin-Secreting Cells, Serum Albumin",
author = "Urd Kielgast and Meena Asmar and Sten Madsbad and Holst, {Jens Juul}",
year = "2010",
doi = "10.1210/jc.2009-2440",
language = "English",
volume = "95",
pages = "2492--6",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "Oxford University Press",
number = "5",
}
RIS
TY - JOUR
T1 - Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients
AU - Kielgast, Urd
AU - Asmar, Meena
AU - Madsbad, Sten
AU - Holst, Jens Juul
PY - 2010
Y1 - 2010
N2 - The mechanism by which glucagon-like peptide-1 (GLP-1) suppresses glucagon secretion is uncertain, and it is not determined whether endogenous insulin is a necessary factor for this effect.
AB - The mechanism by which glucagon-like peptide-1 (GLP-1) suppresses glucagon secretion is uncertain, and it is not determined whether endogenous insulin is a necessary factor for this effect.
KW - Arginine
KW - Blood Glucose
KW - C-Peptide
KW - Diabetes Mellitus, Type 1
KW - Glucagon
KW - Glucagon-Like Peptide 1
KW - Glucagon-Secreting Cells
KW - Humans
KW - Hyperglycemia
KW - Insulin-Secreting Cells
KW - Serum Albumin
U2 - 10.1210/jc.2009-2440
DO - 10.1210/jc.2009-2440
M3 - Journal article
C2 - 20207828
VL - 95
SP - 2492
EP - 2496
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
SN - 0021-972X
IS - 5
ER -